Expert Q&A
Expert Q&A
03/31/2026
Patti Truant Anderson, MPH, PhD
In this interview, Patti Truant Anderson, MPH, PhD discusses recent changes to the latest Dietary Guidelines, highlighting concerns about increased emphasis on animal protein, insufficient focus on fiber,...
03/31/2026
Expert Q&A
Expert Q&A
03/31/2026
Patti Truant Anderson, MPH, PhD
In this interview, Patti Truant Anderson, MPH, PhD discusses recent changes to the latest Dietary Guidelines, highlighting concerns about increased emphasis on animal protein, insufficient focus on fiber,...
03/31/2026
Expert Q&A
Expert Q&A
03/31/2026
Patti Truant Anderson, MPH, PhD
In this interview, Patti Truant Anderson, MPH, PhD discusses recent changes to the latest Dietary Guidelines, highlighting concerns about increased emphasis on animal protein, insufficient focus on fiber,...
03/31/2026
Expert Q&A
Expert Q&A
03/06/2026
Anum Saeed, MD
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
03/06/2026
Expert Q&A
Expert Q&A
03/06/2026
Anum Saeed, MD
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
03/06/2026
Expert Q&A
Expert Q&A
03/06/2026
Anum Saeed, MD
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
03/06/2026
Expert Q&A
Expert Q&A
03/06/2026
Anum Saeed, MD
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
03/06/2026
Expert Q&A
Expert Q&A
03/06/2026
Anum Saeed, MD
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
03/06/2026
Expert Q&A
Expert Q&A
03/06/2026
Anum Saeed, MD
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
03/06/2026
Expert Q&A
Expert Q&A
03/06/2026
Anum Saeed, MD
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
03/06/2026